Arcutis Biotherapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Arcutis Biotherapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2020 to Q2 2024.
  • Arcutis Biotherapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 123M shares, a 101% increase year-over-year.
  • Arcutis Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 69.3M shares, a 25.9% increase from 2022.
  • Arcutis Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 55M shares, a 11.4% increase from 2021.
  • Arcutis Biotherapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 49.4M shares, a 38.5% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 123M +62.1M +101% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 111M +49.9M +81.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 69.3M +14.3M +25.9% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 61.7M +4.64M +8.12% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 61.4M +10M +19.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 61.2M +10.7M +21.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 55M +5.63M +11.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 57.1M +6.99M +14% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 51.4M +1.42M +2.84% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 50.5M +3.23M +6.84% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 49.4M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-27
Q3 2021 50.1M +12.3M +32.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 50M +12.4M +33% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 47.3M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 37.7M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 37.6M Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.